Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

This publication has 98 references indexed in Scilit:

• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Pharmacokinetics of a Transdermal Testosterone System in Men with End Stage Renal Disease Receiving Maintenance Hemodialysis and Healthy Hypogonadal Men
  Journal of Clinical Endocrinology & Metabolism, 2001
• EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON SERUM PSA IN PATIENTS WITH KLINEFELTER SYNDROME
  Archives of Andrology, 2001
• Testosterone
  Drugs & Aging, 2000
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Biological Variation of Total, Free and Percent Free Serum Prostate Specific Antigen Levels in Screening Volunteers
  Journal of Urology, 1997
• The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men
  New England Journal of Medicine, 1996
• Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controls
  Clinical Endocrinology, 1994
• Effect of long‐term oral testosterone undecanoate treatment on prostate volume and serum prostate‐specific antigen concentration in eugonadal middle‐aged men
  The Prostate, 1993
• Estradiol and testosterone metabolism and production in men with prostatic cancer
  The Journal of Steroid Biochemistry and Molecular Biology, 1989